Prognostic impact of MYC, BCL2, BCL6 and Ki67 expression in DLBCL patients treated with CHOP.

<p>Patients’ tumors were stained for (A, B) MYC, (C, D) BCL2, (E, F) BCL6, and (G, H) Ki67. The numbers of patients showing negative or positive stainings (MYC≥40%, BCL2≥70%, BCL6≥50%, Ki67≥90%), cut-off values, and <i>P</i> values are indicated.